Immunology

Next-gen vaccines set to maintain immunity as the years advance

Vaccine potency drops in the elderly and little is known about why this happens. Now, European scientists are on a mission to understand waning immunity and to develop strategies that make vaccines work effectively in all ...

Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

Medications

Drug modifies epigenome in aggressive brain tumors

A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent glioblastoma, changed a DNA process within their brain tumors, according to results from a phase 1 clinical ...

page 6 from 17